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Abstract 
The characteristics of amino acid effiux from pre-loaded cells in incubated slices of rat cerebral cortex have been 
investigated under basal conditions (isosmotic media, 315 mosmol/kg) and following mild hyposmotic shock (265 
mOsmol/kg). Rates of effiux have been correlated with the extent of cell swelling in hyposmotic media. Hyposmolality 
accelerated the slow phase of cellular effiux of L-aspartate ( + 29%), y-aminoisobutyric a id (GABA) ( + 38%), L-glutamate 
(+ 28%) and glycine (+26%). The anion transport inhibitor 4,4'-diisothiocyanatostilbene-2,2'-sulfonic acid (DIDS, 25 or 
100/xM) as well as trifluoperazine (TFP, 25 /.tM), an inhibitor of calmodulin activation, both retarded effiux in hyposmotic 
media, with associated cell swelling (increase in slice non-inulin space). The effects of DIDS and TFP were not additive. 
N-Ethylmaleimide (NEM, 100/~M) significantly retarded the effiux of neutral amino acids, with cell swelling: these effects 
were less pronounced in cells loaded with acidic amino acids. It is concluded that the hyposmotically-activated effiux of 
carboxylic amino acids, and associated cell swelling limitation, requires calmodulin activation and the presence of free 
sulfydryl groups. 
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1. Introduction 
An important feature of brain cells' resistance to 
swelling following exposure to hyposmotic media is 
their ability to lower their internal osmotic potential 
by shedding amino acids [1]. The most abundant 
amino acids subserving this role are aliphatic, straight 
chain, non-essential carboxylic amino acids and the 
Abbreviations: AOA, (aminooxy)acetic a id; CaM, calmod- 
ulin; DIDS, 4,4'-diisothiocyanatostilbene-2,2'-sulfonic acid; 
GABA, y-aminoisobutyric a id; NEM, N-ethylmaleimide; PEG 
4000, polyethyleneglycol 4000; Pipes, piperazine-N,N'-bis-2- 
ethanesulfonic a id; -SH, sulfydryl group; Tris, 2-amino-2-(hy- 
droxymethyl)propane- 1,3-diol. 
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sulfonic amino acid taurine. Cerebral cortical levels 
of these amino acids decrease significantly during 
chronic hyponatraemia in young mice [2] and adult 
rats [3,4]. In recent years several studies have exam- 
ined the mechanism(s) of amino acid release from 
cultured glial and neuronal cells subjected to acute 
hyposmotic shock [5-9]. 
The present study was designed to examine some 
of the characteristics of basal (isosmotic) and hypos- 
motically-activated ffiux of four major cerebral car- 
boxylic amino acids (L-aspartate, GABA, L-glutamate 
and glycine) from pre-loaded cells in slices of rat 
superficial cerebral cortex. Relatively few studies of 
this type have been performed using tissue slices 
(e.g., see Refs. [10-12]). Slices have the advantage 
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that they represent whole tissue, while allowing rela- 
tively rapid manipulation of the extracellular environ- 
ment. As a mixed cell population, however, they 
inevitably pose interpretational problems relating to 
glial and neuronal contributions to amino acid effiux 
(or its inhibition) (see Section 3 and, for comprehen- 
sive review, Ref. [13]). This study also seeks to relate 
rates of amino acid efflux to the ability of cells to 
regulate their volume under hyposmotic onditions. 
The findings indicate that whereas volume-regu- 
latory effluxes of neutral and acidic carboxylic amino 
acids have several common characteristics, these dif- 
fer in certain respects from those of taurine under 
comparable xperimental conditions [14,15]. Some of 
the present findings have previously been published 
as an Abstract [16]. 
2. Materials and methods 
Experiments were carried out on superficial slices 
from the cerebral cortices of adult male Wistar rats 
(200-250 g). Animals were killed by cervical dislo- 
cation and decapitation. The skull was opened and 
individual cortices rapidly transferred to ice-cold aer- 
ated medium (Preparation medium) constituted as 
follows (mmol/1): Na + 142, K+5.4, Ca 2+ 1.8, Mg 2+ 
0.8, C1-124, NO326, HzPO 4 1, SO~- 0.8, glucose 
10, calculated osmolality 315 mOsmol/kg,  pH was 
adjusted to 7.4 by addition of solid Tris. PEG 4000 
(5% w/v)  was added to prevent cell swelling (see 
Refs. [14,17]). Slices (2.00-300 /xm thickness) were 
cut freehand using a chilled razor-blade. This tech- 
nique, while laborious, has been reported to produce 
slices of greater physiological viability than those 
prepared by mechanical chopping [18]. 
Slices were loaded with amino acid at room tem- 
perature (18-20°C) for 120 min. Loading medium 
resembled Preparation medium with the following 
exceptions: (i) amino acids L-aspartate, GABA, L- 
glutamate and glycine were incorporated (1 mmol/1, 
including approx. 200 kBq/m114C-labelled acid, New 
England Nuclear: in a small number of experiments 
[3H]D-aspartate was used); (ii) appropriate metabolic 
inhibitors were included (see below) (iii) NO 3 was 
replaced with equimolaJr HCO 3 and pH adjustment 
to 7.4 was achieved by addition of solid PIPES (gas 
phase 100% O2). HCO 3 was included in the medium 
as it is a physiological anion, but chemical buffering 
was preferred to the use of 95% 02/5% CO 2 since 
the former has been found, in comparable studies, to 
confer greater pH stability [15]. Moreover, the use of 
CO 2 presupposes co-identity of pCO 2 and pH in the 
bulk extracellular phase and within the slice intersti- 
tium: this assumption may not be valid (e.g., see Ref. 
[19]). 
Efflux of amino acids into vigorously shaken amino 
acid-free Efflux media was studied by serial sampling 
over 60 min at 18-20 ° as previously described [14,15]. 
Except for the omission of amino acids, Effiux 
medium had the same composition as Loading 
medium, with the variants listed under (i)-(iv) below. 
Slices were then leached for 18 h in order to extract 
residual activity. Activities of efflux and leachate 
fluids were measured using a Tri-Carb 2000CA/LL 
Liquid Scintillation Analyzer, and efflux expressed in 
terms of rate constant k(10 -2 × min- 1). 
The following modifications/additions were made 
to the Efflux medium: 
(i) As well as effiux into isosmotic media (315 
mOsmol/kg,  see above), loss of amino acids was 
studied also in media rendered hyposmotic by reduc- 
tion on Na + and CI- concentrations to 117 and 99 
mmol/1, respectively (calculated osmolality 265 
mOsmol/kg).  The effects of modification (ii)-(v) 
were examined in hyposmotic as well as isosmotic 
media. 
(ii) Addition of the anion transport inhibitor DIDS 
(Sigma Chemical). While detailed dose: response re- 
lationships were not examined, it was found in pilot 
studies (not reported here in detail) that whereas 25 
/zmol/1 was sufficient o elicit significant inhibition 
of hyposmotically activated efflux of GABA and 
glycine (with accompanying cell swelling), 100 
/xmol/1 were required to produce comparable re- 
sponses in media containing L-aspartate or L-gluta- 
mate (see Section 3). 
(iii) Addition of pimozide (Sigma Chemical, 10 
/xM) or TFP (Aldrich Chemical, 25 /xM), both of 
which are reported to inhibit CaM activation [20]. In 
some experiments TFP and DIDS were both present 
in efflux media. 
(iv) Addition of NEM (Sigma Chemical, 100 
/xmol/1). NEM is a low-specificity inhibitor of mem- 
brane amino acid transport, and a modifier (via alky- 
lation) of -SH groups. 
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2.1. Measurements of cellular volume 
For each of the incubatory variants listed above, as 
well as in isosmotic and hyposmotic ontrol media, 
steady-state cell volumes were estimated as slice 
non-inulin space, during the final 20 min of 60 min 
exposure to appropriate Efflux medium, using 
[14C]carboxyl inulin (Amersham International) and 
following 2 h loading with the appropriate amino 
acid. Full experimental details, as well as an appraisal 
of the validity and limitations of this technique, have 
been published previously [14]. 
2.2. Cellular uptake of amino acids 
In order to assess the ability of cells in slices to 
concentrate amino acids present in the bathing 
medium, freshly prepared slices (3-6 mg) were 
weighed to the nearest 50 /zg on a torsion balance 
and incubated for 10-120 min in loading medium 
containing 1 mmol/1 'cold' amino acid and radiola- 
belled amino acid (approx. 20 kBq/ml). After re- 
moval from the medium they were briefly rinsed in 
'cold' medium, gently blotted on a glass cover slip, 
reweighed, and leached in 1 ml distilled water for 18 
h. The activity of the leachate was measured. No 
significant weight changes were observed in slices 
incubated for up to 120 min (Awt = + 5% or less). 
The following data, derived from Ref. [14], were 
used to calculate (by simple proportion) intracellular 
amino acid concentrations (mmol/ l  cell water): (i) 
slice dry matter constitutes 21% fresh slice weight 
and does not (absolutely) vary during incubation, (ii) 
mean slice post-loading (120 min) extracellular (in- 
ulin) and intracellular (non-inulin) volumes are 1.33 
and 2.42 ~ l /mg dry weight, respectively (i.e., 28% 
and 51% slice wet weight). 
2.3. Metabolic inhibition 
In studies of this nature it is an important consider- 
ation that amino acids should not undergo intra- 
cellular metabolism - i.e., that the accumulated and 
effluxed molecules be chemically identical. In the 
present study AOA (Sigma Chemical, 0.1 mmol/1) 
was used to inhibit transamination. In preliminary 
studies, based on Ref. [21], it was found that of 
14CO2 release during non-inhibited amino acid incu- 
bations was reduced to insignificant levels by use of 
AOA. For incubations incorporating L-glutamate, me- 
thionine DL-sulfoximine (Sigma Chemical, 1 mmol/1) 
was added in order to inhibit glutamine synthetase 
[22]. o-Aspartate has been widely used as a non- 
metabolisable analogue of the acidic amino acids 
(e.g., Refs. [12,23,24]), and although the presence of 
D-amino acid oxidase has recently been reported in 
rat brain, it is absent from the cortex [25]. Cyclohex- 
imide (1 mmol/1, Sigma Chemical) was added to all 
media (except those containing D-aspartate or GABA) 
to inhibit incorporation i to protein. 
The statistical treatment of results, including com- 
puterized estimates of efflux rate constants, have 
been described previously [14]. Mean values are 
quoted ___ S.E.M. (n). Statistical comparisons were 
made on the basis of Student's unpaired t-test, with 
differences for which P < 0.05 or better being re- 
garded as significant. All means include data ob- 
tained from the brains of not fewer than 2 age- and 
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Fig. 1. Uptake of L-aspartate (11), GABA (0) ,  L-glutamate ([3) 
and glycine (O) by cells in incubated slices of rat cerebral 
cortex. Intracellular concentrations calculated as described in 
Section 2. Values are mean+S.E.M. (n=6)  (single error bars 
where these would otherwise overlap). 
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weight-matched litter mates. Incubations in isosmotic 
and hyposmotic media were carried out on slices 
from the opposite cerebral hemispheres of the same 
animal. In no instances were significant inter-individ- 
ual differences noted. 
3. Results 
3.1. Cellular amino acid uptake 
Fig. 1 illustrates the uptake of L-aspartate, GABA, 
L-glutamate and glycine by cells in isosmotically 
incubated slices of rat cerebral cortex, calculated on 
the assumption that intracellular volume approxi- 
mates to slice non-inulin space (see Section 2). Since 
inulin is not an ideal m~xker for extracellular volume 
(e.g., see Refs. [26,27]), the amino acid concentra- 
tions shown in Fig. 1 can only be regarded as approx- 
imations: but the findings clearly show that cells are 
capable of considerable concentrative uptake of the 4 
amino acids used in this study, acidic species being 
more avidly accumulatecl (within 120 min) than neu- 
tral ones. The concentrations at 120 min correspond 
to those at the end of the; loading phase and hence the 
commencement of the effiux phase. 
3.2. Effiux of amino acids 
As with taurine [14,115], the efflux of carboxylic 
amino acids occurred in 3 mono-exponential phases 
(based on the least sum of squares). Possible reasons 
for this, including the likelihood that the 2 slower 
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Fig. 2. Time-course for the effiux of [14C]GABA from pre-loaded 
slices of cerebral cortex into isosmotic medium. Each point 
represents he mean of 6 slices (error bars shown at 15-60 min). 
The steep solid line indicates the 2nd phase effiux (k = 0.29+ 
0.06(6)rain-l). For further details, see text. 
phases represent intracellular loss, and may originate 
from concentrated (vesicular) and diffuse (cytosolic) 
compartments, have been discussed previously [14]. 
The 3rd, slowest phase is the only one on which it is 
possible to perform kinetic analyses that are suffi- 
ciently accurate to permit statistical discrimination 
between rates of efflux under differing incubatory 
conditions, and all rate constants reported here refer 
to this phase. A typical pattern of efflux (for GABA) 
is shown in Fig. 2. 
Table 1 
Rate constants (k) for the 3rd (presumed cellular) phase of amino acid effiux in cerebral cortical slices incubated in isosmotic (315 
mOsmol /kg)  and hyposmotic (265 mOsmol /kg)  media, and corresponding steady-state c ll volumes. 
Rate con,;tants (k X 10-2min - l) Cell vol. ( /x l /mg dry wt.) 
Isosmotic Hyposmotic P Isosmotic Hyposmotic P 
Amino acid-free - - - 2.44 _ 0.10(12) 2.89 ___ 0.10(13) < 0.005 
L-Aspartate 0.34 _ 0.03(6) 0.44 + 0.03(6) < 0.05 2.34 _ 0.07(11) 2.56 +__ 0.11(14) a n.s. 
D-Aspartate 0.28 + 0.03(6) 0.37 + 0.03(6) 0.1 > P > 0.05 - - - 
GABA 0.55 + 0.05(6) 0.76 + 0.06(6) < 0.025 2.31 _ 0.12(10) 2.53 _ 0.09(12) b n.s. 
L-Glutamate 0.32 _ 0.02(6) 0.41 + 0.03(6) < 0.05 2.38 ___ 0.08(11) 2.60 + 0.08(12) a 0.1 > P > 0.05 
Glycine 0.70 +__ 0.04(6) 0.88 + 0.05(6) < 0.025 2.29 + 0.09(13) 2.59 + 0.08(12) a < 0.05 
Volumes are also shown following incubation in amino acid-free media. Values are mean ___ S.E.M. (n). The significance of differences 
between isosmotic and hyposmotic incubations are shown in the 3rd and 6th columns. For cell volumes, significances of differences 
between amino acid media and amino acid-free media are indicated as follows: a p < 0.05, b p < 0.01, n.s. = not significant 
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Fig. 3. The effects of DIDS (25 /xmol/1)  (GABA and glycine) 
or 100 /xmol/1 (L-glutamate)) on the rate constants for the 3rd 
(presumed cellular) phase of amino acid effiux from cerebral 
cortical slices incubated in hyposmotic media, and corresponding 
steady-state c ll volumes. Open and hatched bars represent con- 
trol values and values in the presence of DIDS respectively. 
Results are shown as mean + S.E.M. For rate constants n = 6. For 
cell volumes n = 10 or 11. Significance of differences between 
control values and values in the presence of DIDS are shown as 
*P<0.05 ,  ** P<0.01 ,  *** P<0.001.  
* 
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Fig. 4. The effects of TFP (25 /zmol /1 )  on the rate constants for 
the 3rd (presumed cellular) phase of amino acid effiux from 
cerebral cortical slices incubated in hyposmotic media, and corre- 
sponding steady-state c ll volumes. Open and hatched bars repre- 
sent control values and values in the presence of TFP respec- 
tively. Results are shown as mean + S.E.M. For rate constants 
n = 6. For cell volumes n = 12 or 13. Significance of differences 
between control values and values in the presence of TFP are 
shown as * P < 0.05, * * P < 0.01. 
Table 1 shows the rates of effiux of amino acids in 
isosmotic and hyposmotic media, and the correspond- 
ing steady-state c ll volumes. Effiux (i) was signifi- 
cantly accelerated in hyposmotic media, and (ii) was 
more rapid for neutral than for acidic amino acids. 
Also shown in Table 1 are effiux rates for D-aspar- 
tate; these do not differ significantly from those for 
L-aspartate and L-glutamate. Hyposmotic stress led to 
moderate, non-osmometric cell swelling, which was 
significant at the level P < 0.05 only for glycine. 
Also included in Table 1 are the volumes of cells 
exposed to effiux media following 2 hour incubation 
in amino acid-free Loading media. The presence of 
amino acids in Loading media (with consequent cel- 
lular accumulation) had no effect on cell volumes 
during effiux in isosmotic media, but significantly 
reduced cell swelling in hyposmotic media. The rates 
of effiux of D-aspartate were not examined under the 
modified incubatory conditions described below. 
Those for L-aspartate (as well as the corresponding 
cell volumes) were in no instance significantly differ- 
ent from those for L-glutamate, and have accordingly 
been omitted from Figs. 3-5. 
3.3. Effects of anion transport inhibition 
The presence of the anion transport inhibitor DIDS 
had no significant effects on amino acid effiux or cell 
volumes in isosmotic media: Fig. 3 summarizes the 
effects of DIDS in hyposmotic media. For each acid 
there was significant retardation of effiux (by com- 
parison with control values), accompanied by signifi- 
cant cell swelling to levels approximating to those 
observed in amino-acid free hyposmotic media (Ta- 
ble 1). 
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Fig. 5. The effects of NEM (100 /xmol/1) on the rate constants 
from the 3rd (presumed cellular) phase of amino acid effiux from 
cerebral cortical slices incubated in hyposmotic media, and corre- 
sponding steady-state c ll volumes. Open and hatched bars repre- 
sent control values and values in the presence of NEM, respec- 
tively. Results are shown as mean+ S.E.M. For rate constants 
n = 6. For cell volumes 10 < n _< 13. Significance of differences 
between control values and values in the presence of NEM are 
shown as * P<0.05 ,  ** P<0.01 ,  *** P<0.001.  n .s .=not  
significant. 
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3.4. Effects of CaM inhibition 
In isosmotic media inhibition of CaM activation, 
like inhibition of anion transport, led to small, statis- 
tically insignificant, slowing of amino acid effluxes, 
and was without effect on cell volume. Effects of 
TFP on these variables in hyposmotic media are 
shown in Fig. 4. By comparison with control data 
there was significant retardation of amino acid efflux 
with cell swelling. Pimozide, like TFP, had no signif- 
icant effects on effluxes or cell volumes in isosmotic 
media: it had quantitatively similar effects to TFP 
under hyposmotic onditions (results not shown in 
detail). 
When present in the same hyposmotic efflux me- 
dia, the effects of TFP ~md DIDS were not additive. 
The fo l lowing values for rate constants 
(X 10-2min -1) and cel]t volumes ( /x l /mg dry wt.) 
in no case differ significantly from the corresponding 
values shown in Figs. 3 and 4: GABA, 0.55 + 0.04(6), 
2.79 _ 0.08(9); L-glutamate, 0.34 _+ 0.02(6), 3.04 _+ 
0.15(11); glycine, 0.63 -~: 0.05(6), 2.85 _+ 0.10(11). 
3.5. Effects of NEM 
NEM had no significant effects on amino acid 
effiux in isosmotic media, nor did it influence cell 
volumes. Its effects in hyposmotic media are summa- 
rized in Fig. 5. Effiux of GABA and glycine was 
strongly inhibited, with accompanying cell swelling. 
Qualitatively similar results were obtained in cells 
pre-loaded with L-glutamate, but did not achieve 
statistical significance. 
4. Discussion 
These results demonstrate hat a reduction of extra- 
cellular osmolality, not exceeding that which is en- 
countered in pathophysiological hyponatraemia [28], 
leads to significant acce, leration of the net efflux of 
acidic and neutral amino acids from cells in incu- 
bated slices of rat cerebral cortex, and that this is 
associated with cell swelling limitation (Figs. 3-5). 
Loss of amino acids is not, however, the only vol- 
ume-regulatory mechanism available to hyposmoti- 
cally stressed cells (e.g., see Ref. [29]), and it is not 
clear why cells pre-loaded with amino acids should 
apparently effect swelling limitation more success- 
fully than cells previously exposed to amino acid-free 
media. While endogenous amino acids (and inositol, 
also a volume-regulatory effector in brain cells [30]) 
would presumably have been shed during amino 
acid-free loading, it might have been expected that 
volume-regulatory loss of K and C1 would remain 
available to cells following hyposmotic stress. But 
the present findings must only be viewed in the 
context of the specific experimental model; compari- 
son with regulatory responses and mechanisms in 
other cell preparations, e.g., cultured cells (see be- 
low), or extrapolation to possible responses of cells in 
vivo, must be made with caution. One obvious uncer- 
tainty in the present experimental model concerns the 
use of inulin in the determination of cell volume, as 
has been discussed previously [14]. Moreover, there 
can be no certainty that amino acid metabolism was 
completely abolished, although the correspondence of 
the rates of effiux of o-aspartate, L-aspartate and 
L-glutamate (Fig. 1) suggest hat this was achieved 
for the dicarboxylic acids. Essentially, what the pre- 
sent findings illustrate are the qualitative differences 
between cellular responses to specific incubatory 
conditions (viz. swelling vs. swelling limitation, ac- 
celeration vs. retardation of effiux). With this caveat 
in mind, a number of valid conclusions can be drawn. 
In confirmation of what has been observed in 
cultured astrocytes [8] the rates of effiux of car- 
boxylic amino acids are slower than those of taurine 
under hyposmotic (and isosmotic) conditions [14]. 
The inhibitory effect of DIDS on effiuxes, with 
accompanying cell swelling, confirms observations in
cultured astrocytes [5,7] and cerebellar neurons [7]. 
This implies either that a significant fraction of ef- 
fluxed amino acids are in the anionic form (depend- 
ing upon their individual pK a) or that loss of zwitte- 
rionic amino acids may occur via DIDS-inhibitable 
anion selective channels. The existence of such chan- 
nels, permeable to low molecular weight organic 
molecules, including acidic and neutral amino acids, 
has been proposed in a variety of cultured brain cell 
preparations [5,31-33], and for recent review, [34]. 
As previously reported [16] ICs0 for the inhibitory 
effect of DIDS on glycine effiux (-- 12 /xM) is less 
than that required for L-glutamate fflux inhibition 
(~ 55 /xM). In the present study GABA effiux was 
inhibited to an extent comparable with that of glycine 
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by the presence of 25/xM DIDS (Fig. 3). While there 
is no ready explanation for the apparent discrepancy 
in the sensitivities of efflux to the effects of DIDS, it 
is unlikely to reflect he existence of discrete neutral 
and acidic amino acid efflux pathways. Previous 
studies on the efflux of various carboxylic amino 
acids from cultured astrocytes and cerebellar granule 
neurons indicate variations in permeancy but do not 
suggest he presence of multiple pathways [8,32,33]. 
It is possible that inhibitor/transport pathway (chan- 
nel) interactions differently effect the permeability of 
the pathway to the two classes of amino acid (e.g., 
sterically or by charge effects), but, as with channel 
multiplicity, there is at present no evidence in support 
of such an hypothesis. 
The requirement for CaM activation in facilitating 
volume-regulatory amino acid efflux in response to 
hyposmolality has also been postulated in other cell 
types, e.g., ascites tumour cells [35], in which efflux 
is inhibited by TFP and pimozide. Neither of these 
drugs is highly specific for CaM inhibition, but in the 
present study their effects on amino acid efflux and 
cell volumes were closely similar, and were exerted 
at a molar ratio comparable with that previously 
reported for their inhibitory effect on cell volume 
recovery following hyposmotic stress in ascites tu- 
mour cells [35]. The effects of TFP on these variables 
are shown in Fig. 4, and it is likely, though not 
proven, that these reflect CaM inhibition. TFP also 
inhibits volume-regulatory taurine release in hypos- 
motically stressed brain cells [14]. An important con- 
sideration, however, is that whereas the inhibitory 
effects of DIDS and TFP on taurine release are 
strongly additive [14], no such effect was observed in 
the present study. This supports the suggestion that 
taurine release occurs by at least two independently- 
inhibitable mechanisms [15], whereas efflux of car- 
boxylic amino acids may occur via a single popula- 
tion of anionic, CaM-dependent diffusive pathways. 
In a recent study on cultured astrocytes it was 
reported that TFP increased, rather than decreased, 
efflux of D-aspartate from pre-loaded cells, and that 
this decrease was proportional to the degree to which 
cell volume regulation was inhibited: in contrast, 
taurine release was inhibited [36]. Increased release 
of D-aspartate might thus reflect he sustained activity 
of swelling-activated (and presumably CaM-indepen- 
dent) diffusive channels, whereas reduction in the 
rate of release of taurine via CaM-dependent chan- 
nels would prevent it from exerting its role of an 
effector of swelling limitation. This raises the impor- 
tant question of the extent o which accelerated amino 
acid efflux is a cause or consequence of volume 
responses to hyposmotic stress (or their inhibition) 
and whether there is in fact any correlation between 
these events. One complicating factor is that amino 
acid effluxes in cultured cells are usually followed 
immediately subsequent to the imposition of hypos- 
motic stress, during which transient cell swelling is 
succeeded by rapid reduction of volume (the phase of 
so-called regulatory volume decrease). In the present 
study only the slow phase of efflux was studied, and 
cell volume determinations made 40-60 minutes ub- 
sequent to hyposmotic shock. At this time both vari- 
ables can be presumed to have been in near steady- 
state, rather than undergoing transient flux. Compari- 
son between results obtained using brain slices and 
cultured cells is further complicated by the fact that 
observed net rates of efflux from slices represents he 
balance between cellular loss and subsequent re-up- 
take from the interstitium, a consideration which does 
not apply in the case of superfused cultured monolay- 
ers. Of particular interest in this context is a recent 
study in which it has been shown that amino acids, 
notably taurine, shed by neurons may be sequestered 
by glia during hyposmotic stress [37]. There is evi- 
dence that the magnitude and tortuosity of the inter- 
stitial space in slices are similar to those in vivo [38]. 
Moreover, slices comprise a mixed cell population, 
although available data indicate that hyposmotically- 
activated amino acid losses from glia and neurons are 
comparable [7,39]. A consistent inverse correlation 
has been shown between cell volumes and rates of 
slow amino acid efflux (Table 1, Figs. 3-5), which 
argues in favour of net efflux as a volume-regulatory 
effector mechanism during this phase of response to 
hyposmotic stress. 
The importance o f -SH groups in the volume 
responses of hyposmotically incubated cells was first 
studied in detail in lymphocytes [40], and recent 
studies indicate that these groups are also implicated 
in the release of amino acids from brain cells [41,42]. 
There appears, however, to be a lack of consistency 
in regard to the responses observed when -SH block- 
ing agents have been used as an investigative agent, 
which may be attributed to differing site specificity 
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or physiochemical properties of these compounds 
[41]. Differing experimental models may contribute 
to these divergences. F'or example, in the present 
study NEM, which strongly inhibited efflux of neu- 
tral amino acids (with cell swelling), only slightly 
affected these variables in cells loaded with L-glu. 
This contrasts with the recent finding that in cultured 
astrocytes NEM inhibits hyposmotically stimulated 
efflux of D-aspartate [411]. 
In conclusion, the present results show that hypos- 
motically stimulated efflux of carboxylic amino acids 
from cerebral cortical cells is associated with cell 
swelling limitation, and that this limitation is im- 
paired by manoeuvres !Ehat depress rates of efflux, 
viz. (i) the presence of the anion transport inhibitor 
DIDS (which suggests that efflux occurs via anion- 
selective pathways), (ii) the presumed inhibition of 
CaM activation by TFP or pimozide, and (iii) the 
acetylation of -SH groups by NEM. Both DIDS and 
NEM exert their effects to a quantitatively different 
extent in cells pre-loaded with neutral or acidic amino 
acids. But their effects were qualitatively comparable, 
and it is probable that efflux of both classes of amino 
acids occurs via a common population of anionic, 
hyposmotically-activated diffusion pathways analo- 
gous to those that have: been described in cultured 
brain cells [5,31,32] and several non-excitable cell 
types [43-47]. The results do, however, reveal certain 
differences in the efflux characteristics of carboxylic 
amino acids as compared with those of taurine [ 14,15], 
although it is not possible from the present findings 
the extent (if any) to which these might reflect differ- 
ences between euronal and glial responses. 
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